Sarah George
Infectious Disease · Saint Louis, MONPI 1215994975
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,220 of the $2,935 with a category attached, or 75.6%. Every reported general payment came from a single manufacturer, Merck.
Across 8 payments — averaging $366.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$3K
Across 125 payments — averaging $14,532 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Emergent Biosolutions Inc.$646K
- Sanofi Pasteur Inc.$601K
- Pfizer$402K
- Bavarian Nordic A/s$116K
- Sanofi US Services Inc.$52K
What the payments were for
- Consulting fees$2,22076%
- Travel & lodging$44815%
- Food & beverage$2679%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 8 | $2,935 |
How this compares
$2,935 in reported general payments places this provider in the 75th percentile of 177 infectious disease providers in Missouri.
Other infectious disease in Saint Louis
- Robert BelsheSaint Louis$382K
- Erik DubberkeSaint Louis$144K
- Rupa PatelSaint Louis$96K
- Michael DiamondSaint Louis$44K
- Andrej SpecSaint Louis$26K
- William PowderlySaint Louis$20K
- Elvin GengSaint Louis$15K
- Matifadza HlatshwayoSaint Louis$11K
- Bernard CaminsSaint Louis$11K
- Joseph CherabieSaint Louis$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.